Xerox Holdings Corp (XRX)

Total Costs & Expenses

$7.80B

TTM · Period ending: · USD

XRX logo

XRX Total Costs & Expenses

Latest reported$7.80B
XRX TTM Total Costs & Expenses (-$8.83B → $7.80B)
High-resolution chart · PNG

XRX total costs & expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Xerox Holdings Corp Total Costs & Expenses — Trailing twelve months (TTM) (USD)
Period endingTotal Costs & Expenses (USD)
7,796,000,000
7,452,000,000
7,092,000,000
6,683,000,000
6,044,000,000
6,008,000,000
6,062,000,000
6,163,000,000
6,294,000,000
6,441,000,000
6,540,000,000
6,635,000,000
6,732,000,000
6,817,000,000
6,885,000,000
6,818,000,000
6,829,000,000
6,767,000,000
6,721,000,000
6,773,000,000
6,725,000,000
6,457,000,000
6,605,000,000
6,841,000,000
7,134,000,000
7,731,000,000
7,919,000,000
8,104,000,000
8,269,000,000
8,505,000,000
8,738,000,000
9,019,000,000
9,189,000,000
9,243,000,000
9,334,000,000
9,279,000,000
10,937,000,000
12,723,000,000
14,533,000,000
16,429,000,000
16,907,000,000
17,112,000,000
17,214,000,000
17,504,000,000
17,810,000,000
18,381,000,000
18,936,000,000
19,477,000,000
19,611,000,000
19,727,000,000
20,007,000,000
20,221,000,000
20,355,000,000
24,208,000,000
24,285,000,000
24,216,000,000
24,449,000,000
20,780,000,000
20,664,000,000
20,202,000,000
20,012,000,000
19,951,000,000
18,179,000,000
17,199,000,000
15,621,000,000
14,055,000,000
14,176,000,000
14,256,000,000
14,765,000,000
15,390,000,000
16,025,000,000
16,372,000,000
16,247,000,000
15,835,000,000
15,221,000,000
14,532,000,000
14,211,000,000
14,057,000,000
14,102,000,000
14,221,000,000
14,084,000,000
14,041,000,000
13,933,000,000
14,362,000,000
14,315,000,000
14,176,000,000
14,484,000,000
14,056,000,000
14,070,000,000
14,137,000,000
13,864,000,000
13,803,000,000
13,802,000,000
13,844,000,000
14,081,000,000
13,906,000,000
14,549,000,000
15,172,000,000
15,774,000,000
17,218,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.